,

Treatment of Central Sleep Apnea with Adaptive Servoventilation in Chronic Heart Failure

June 24, 2015 at 12:05 am

Preliminary results from a recent study of adaptive servo-ventilation (ASV) therapy for the treatment of central sleep apnea in patients with heart failure and reduced ejection fraction indicate an increased risk of cardiovascular death associated with this treatment. An analysis of the trial results and recommendations for the clinical management of patients receiving ASV therapy has been published online ahead of print publication in the American Journal of Respiratory and Critical Care Medicine. Read “Treatment of Central Sleep Apnea with Adaptive Servoventilation in Chronic Heart Failure” by Najib T Ayas, MD, PPH, Susheel P. Patil, MD, Michael Stanchina, MD, and ATS President Atul Malhotra, MD. The ATS also has developed a resource for patients: “Use of Adaptive Servo-ventilation (ASV) for People With Heart Failure and Trouble Sleeping.”

Advertisement

ATS 2016 Full Registration